Stem cells are mobilized from the bone marrow to the peripheral blood as a source of stem cells for transplantation in cancer and genetic diseases. Exactly how the mobilization-inducing drugs operate has not been clear—but the answer may lie partly with the stimulation of bone-forming cells by signals from the sympathetic nervous system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Katayama, Y. et al. Cell 124, 407–421 (2006).
Wilson, A.T.A. Nat. Rev. Immunol. 6, 93–106 (2006).
Lord, B.I., Testa, N.G. & Hendry, J.H. Blood 46, 65–72 (1975).
Zhang, J. et al. Nature 425, 836–841 (2003).
Calvi, L.M. et al. Nature 425, 841–846 (2003).
Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C. & Morrison, S.J. Cell 121, 1109–1121 (2005).
Cancelas, J.A. et al. Nat. Med. 11, 886–891 (2005).
Lapidot, T., Dar, A. & Kollet, O. Blood 106, 1901–1910 (2005).
Papayannopoulou, T. Blood 103, 1580–1585 (2004).
Liu, F., Poursine-Laurent, J. & Link, D.C. Blood 95, 3025–3031 (2000).
Levesque, J.P. et al. Blood 104, 65–72 (2004).
Semerad, C.L. et al. Blood 106, 3020–3027 (2005).
Elefteriou, F. et al. Nature 434, 514–520 (2005).
Wagner, J.E. et al. Blood 100, 1611–1618 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cancelas, J., Williams, D. Stem cell mobilization by β2-agonists. Nat Med 12, 278–279 (2006). https://doi.org/10.1038/nm0306-278
Issue Date:
DOI: https://doi.org/10.1038/nm0306-278
This article is cited by
-
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization
Leukemia (2019)
-
Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling
Nature Immunology (2007)
-
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Nature Medicine (2006)